Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Cataract
Share your love
2023 Recap: Top 15 Ophthalmic Medical Devices
In a groundbreaking year for ophthalmic advancements, 2023 has witnessed the launch of cutting-edge medical devices that promise to reshape the landscape of eye care. From augmented reality headsets to innovative surgical systems, the field is experiencing a wave of…
Pediatric Cataract Surgery Restores Vision for Infant
Nethradhama Super Speciality Eye Hospitals achieved a remarkable feat in pediatric eye care with the successful completion of a high-risk paediatric cataract surgery on an 8-month-old baby in Bangalore. Led by Dr. Sri Ganesh, a distinguished eye surgeon and the…
CorNeat Vision Introduces CorNeat EverPatch in the U.S.
CorNeat Vision has launched the CorNeat EverPatch in the United States, a novel synthetic tissue-integrating matrix poised to transform ophthalmic surgeries. Endorsed by leading surgeons across the US, this FDA-cleared device marks a significant advancement in addressing complications associated with…
Amring Names Dr. Donnenfeld as U.S. Advisory Board Chair
Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announced the appointment of Dr. Eric D. Donnenfeld, a distinguished figure in ophthalmology, as the Chair of its U.S. Medical Advisory Board (MAB). This strategic decision comes as the company gears…
Ophthalmology In Ancient Egyptian & Greek Mythology I OBN
The Brightness of Divine Glance In Ancient Egypt One of the first civilizations in human history is that of ancient Egypt. The pioneering work of the ancient Egyptians in the domains of art, medicine, and the mythological storytelling of scientific…
Evmann Holding Eyes Expansion in Ophthalmology at ESCRS
Evmann Investments Holding BV is taking a proactive approach to strengthening its investment footprint in the ophthalmology sector. The Netherlands-based holding company, with operations spanning over 93 countries via its German subsidiary VSY Biotechnology GmbH, is setting a new course…
Lupin Launches Bromfenac Ophthalmic Solution in the US
Lupin Limited announced the launch of Bromfenac Ophthalmic Solution, 0.075%. The product has received the green light from the United States Food and Drug Administration (U.S. FDA), marking a crucial milestone for the company’s expansion in the American pharmaceutical market.…
ESCRS Winter Meeting Starts with Dynamic Program
The European Society of Cataract and Refractive Surgeons (ESCRS) has commenced its highly anticipated Winter Meeting in Frankfurt, Germany. The event, which runs from February 15th to 18th, 2024, promises to be a hub of innovation and knowledge exchange in…
VSY Biotechnology’s 100% Glistening-Free IOL Material
VSY Biotechnology GmbH is pushing the boundaries of ophthalmology with its cutting-edge 100% Glistening-Free IOL Material. In a statement, Andreas Kühnel, the Managing Director at VSY Biotechnology GmbH, expressed his excitement about the groundbreaking innovation, saying, “This innovative solution, developed…
Dry Eye Treatment & Cyclosporine and Side Effect in Dogs
Dry eye disease (DED), also known as keratoconjunctivitis sicca (KCS), is a common disorder of the eye affecting millions of people around the world. The prevalence of DED ranges from 5% to 33% worldwide with increased prevalence among adult women…